F.D.A. Looks to A.I. to Enhance Efficiency

The U.S. Food and Drug Administration (F.D.A.) is exploring how artificial intelligence (A.I.) can streamline its operations, from speeding up drug approvals to improving safety monitoring. Think of it as giving the agency a high-tech assistant to handle mountains of data faster—potentially getting life-saving treatments to patients sooner.